BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31618515)

  • 1. The potential of the combined use of targeted type I interferon pathway inhibitors and oncolytic viruses to treat sarcomas.
    MacNeill AL
    Vet Comp Oncol; 2020 Mar; 18(1):36-42. PubMed ID: 31618515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncolytic reovirus therapy: Pilot study in dogs with spontaneously occurring tumours.
    Hwang CC; Igase M; Sakurai M; Haraguchi T; Tani K; Itamoto K; Shimokawa T; Nakaichi M; Nemoto Y; Noguchi S; Coffey M; Okuda M; Mizuno T
    Vet Comp Oncol; 2018 Jun; 16(2):229-238. PubMed ID: 29076241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncolytic virotherapy of canine and feline cancer.
    Gentschev I; Patil SS; Petrov I; Cappello J; Adelfinger M; Szalay AA
    Viruses; 2014 May; 6(5):2122-37. PubMed ID: 24841386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canine Adipose-Derived Mesenchymal Stem Cells (cAdMSCs) as a "Trojan Horse" in Vaccinia Virus Mediated Oncolytic Therapy against Canine Soft Tissue Sarcomas.
    Petrov I; Gentschev I; Vyalkova A; Elashry MI; Klymiuk MC; Arnhold S; Szalay AA
    Viruses; 2020 Jul; 12(7):. PubMed ID: 32664672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soft-tissue sarcomas in dogs: a review.
    Ehrhart N
    J Am Anim Hosp Assoc; 2005; 41(4):241-6. PubMed ID: 15995161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soft tissue sarcomas.
    Mauldin GN
    Vet Clin North Am Small Anim Pract; 1997 Jan; 27(1):139-48. PubMed ID: 9002173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tyrosine kinase inhibitor toceranib in feline injection site sarcoma: efficacy and side effects.
    Holtermann N; Kiupel M; Hirschberger J
    Vet Comp Oncol; 2017 Jun; 15(2):632-640. PubMed ID: 26762970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytologic grading of canine and feline spindle-cell sarcomas of soft tissues and its correlation with histologic grading.
    Millanta F; Asproni P; Aquino G; Poli A
    Top Companion Anim Med; 2020 Nov; 41():100458. PubMed ID: 32823163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II clinical evaluation of lomustine chemotherapy for feline vaccine-associated sarcoma.
    Saba CF; Vail DM; Thamm DH
    Vet Comp Oncol; 2012 Dec; 10(4):283-91. PubMed ID: 22236148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging therapeutic approaches for canine sarcomas: Pushing the boundaries beyond the conventional.
    Borgatti A; Dickerson EB; Lawrence J
    Vet Comp Oncol; 2020 Mar; 18(1):9-24. PubMed ID: 31749286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tumour activity of oncolytic reovirus against canine histiocytic sarcoma cells.
    Igase M; Shousu K; Fujiki N; Sakurai M; Bonkobara M; Hwang CC; Coffey M; Noguchi S; Nemoto Y; Mizuno T
    Vet Comp Oncol; 2019 Jun; 17(2):184-193. PubMed ID: 30761736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with a combination of doxorubicin, surgery, and radiation versus surgery and radiation alone for cats with vaccine-associated sarcomas: 25 cases (1995-2000).
    Bregazzi VS; LaRue SM; McNiel E; Macy DW; Dernell WS; Powers BE; Withrow SJ
    J Am Vet Med Assoc; 2001 Feb; 218(4):547-50. PubMed ID: 11229507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emergence of combinatorial strategies in the development of RNA oncolytic virus therapies.
    Nguyen TL; Tumilasci VF; Singhroy D; Arguello M; Hiscott J
    Cell Microbiol; 2009 Jun; 11(6):889-97. PubMed ID: 19388908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy with radiation or cisplatin enhances the potency of Ad5/35 chimeric oncolytic adenovirus in a preclinical model of head and neck cancer.
    Ganesh S; Gonzalez-Edick M; Gibbons D; Ge Y; VanRoey M; Robinson M; Jooss K
    Cancer Gene Ther; 2009 May; 16(5):383-92. PubMed ID: 19011598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncolytic gene therapy for canine cancers: teaching old dog viruses new tricks.
    Arendt M; Nasir L; Morgan IM
    Vet Comp Oncol; 2009 Sep; 7(3):153-61. PubMed ID: 19691644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of oncolytic reovirus in canine lymphoma cell lines.
    Hwang CC; Umeki S; Igase M; Coffey M; Noguchi S; Okuda M; Mizuno T
    Vet Comp Oncol; 2016 Aug; 14 Suppl 1():61-73. PubMed ID: 25319493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant chemotherapy for sarcomas and carcinomas.
    Hammer AS; Couto CG
    Vet Clin North Am Small Anim Pract; 1990 Jul; 20(4):1015-36. PubMed ID: 2196728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin is a widely used chemotherapeutic agent with activity reported in many malignancies, including soft tissue sarcomas.
    Greenberg MH; Friedland ML
    Cancer Invest; 1989; 7(5):523. PubMed ID: 2620253
    [No Abstract]   [Full Text] [Related]  

  • 19. Bugs and drugs: oncolytic virotherapy in combination with chemotherapy.
    Wennier ST; Liu J; McFadden G
    Curr Pharm Biotechnol; 2012 Jul; 13(9):1817-33. PubMed ID: 21740354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of an Oncolytic Myxoma Virus in Dogs with Soft Tissue Sarcoma.
    MacNeill AL; Weishaar KM; Séguin B; Powers BE
    Viruses; 2018 Jul; 10(8):. PubMed ID: 30060548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.